0001637132-15-000003.txt : 20151210 0001637132-15-000003.hdr.sgml : 20151210 20151209173404 ACCESSION NUMBER: 0001637132-15-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06c FILED AS OF DATE: 20151210 DATE AS OF CHANGE: 20151209 EFFECTIVENESS DATE: 20151210 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Manzo Pharmaceuticals, Inc CENTRAL INDEX KEY: 0001637132 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 880343833 STATE OF INCORPORATION: NV FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-252734 FILM NUMBER: 151279176 BUSINESS ADDRESS: STREET 1: P O Box 107 CITY: Milford STATE: PA ZIP: 18337 MAIL ADDRESS: STREET 1: P O Box 107 CITY: Milford STATE: PA ZIP: 18337 D 1 primary_doc.xml X0707 D LIVE 0001637132 Manzo Pharmaceuticals, Inc 222-415 Oakdale Road Toronto A6 ONTARIO, CANADA M3N 1W7 647-393-8417 NEVADA None None Corporation true Arthur Douglas Smitherman 222-415 Oakdale Road Toronto A6 ONTARIO, CANADA M3N 1W7 Director Pharmaceuticals $1 - $1,000,000 06c false true true true true false None of the above are planned at this time. 1000 Indefinite 0 Indefinite false 0 5000000 true 5000000 true The gross amount of Sales Commissions & Finder's Fees combined is 10% [$5,000,000.00] based on the entire offering of $50,000,00.00 being sold out. 5000000 true Up to 10% of the offering, including, and/or in combination with Sales Commissions & Finder's Fee's may be paid to A.D. Smitherman. false Manzo Pharmaceuticals, Inc A.D. Smitherman A.D. Smitherman Director 2015-12-09